1910 Genetics
Boston
About 1910 Genetics
1910 Genetics is a biotechnology company integrating AI, computation, and biological automation to improve drug development. The company establishes an understanding of the molecular basis of disease to the granularity at which the world understands sickle cell anemia. This understanding drives their integration of artificial intelligence (AI), computation, and biological automation to accelerate the design of small molecule and protein therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $26.6M
- Last round: Series Unknown (Oct 2024)
- Website: 1910genetics.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/1910-genetics-102123 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.